TherapeuticsMD Inc Capital Reinvestment Ratio

Latest as of March 2024: 712.82x

TherapeuticsMD Inc capital reinvestment ratio. TherapeuticsMD Inc (TXMD) has a Capital Reinvestment Ratio of 712.82x as of March 2024, meaning it reinvests 713% of its operating cash flow ($11.00K) in capital expenditures ($7.84 Million). See TherapeuticsMD Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

712.82x
Capex / Operating Cash Flow

Operating Cash Flow

$11.00K
USD

Capital Expenditures

$7.84 Million
USD

Data as of

Mar 2024
Most recent filing

Capital Reinvestment Ratio of TherapeuticsMD Inc (1993–2006)

Capital reinvestment ratio of TherapeuticsMD Inc from 1993 to 2006. This chart tracks TherapeuticsMD Inc's Capital Reinvestment Ratio across 11 annual periods. See TherapeuticsMD Inc (TXMD) financial flexibility to measure the company's free cash flow as a share of total liabilities.

TherapeuticsMD Inc Capital Reinvestment Ratio by Year (1993–2006)

TherapeuticsMD Inc capital reinvestment ratio by year from 1993 to 2006. For the full cash flow conversion analysis, see cash efficiency ratio of TherapeuticsMD Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2006 0.18x $329.84K $57.75K ▼ -21.7%
2005 0.22x $412.34K $92.23K ▼ -85.1%
2004 1.50x $207.73K $311.05K ▼ -15.4%
2003 1.77x $140.00K $247.71K ▲ +182.6%
2002 0.63x $100.08K $62.66K ▲ +367.2%
2001 0.13x $161.95K $21.70K ▼ -97.2%
1998 4.74x $44.60K $211.37K ▲ +285.1%
1997 1.23x $77.53K $95.40K ▲ +639.6%
1995 0.17x $63.45K $10.56K ▼ -82.8%
1994 0.97x $72.86K $70.35K ▼ -35.9%
1993 1.51x $59.76K $90.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow